(Q28176922)

English

Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial

scientific article (publication date: 13 March 2001)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial (English)

0 references

4

A M Lincoff

0 references

Eric J. Topol

series ordinal

5

object named as

E J Topol

0 references

Stephen G. Ellis

series ordinal

2

object named as

S G Ellis

0 references

author name string

S R Steinhubl

series ordinal

1

0 references

K Wolski

series ordinal

3

0 references

language of work or name

English

0 references

publication date

13 March 2001

0 references

published in

Circulation

0 references

volume

103

0 references

issue

10

0 references

page(s)

1403-9

0 references

Identifiers

DOI

10.1161/01.CIR.103.10.1403

0 references

PubMed publication ID

11245644

0 references

(Q28176922)

Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)